Browsing by Author Burstein, Harold J.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2014Adjuvant exemestane with ovarian suppression in premenopausal breast cancerCoates, Alan; Burstein, Harold J.; Colleoni, Marco; et al, Various; Fleming, G. F.; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Perez, E. A.; Regan, Meredith M.; Tondini, Carlo; Walley, B; School of Public Health: Public HealthAdjuvant exemestane with ovarian suppression in premenopausal breast cancer, New England Journal of Medicine, vol.371, 2, 2014,pp 107-118
2016Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trialCoates, Alan; Bellet, Meritxell; Bernhard, Jurg; Burstein, Harold J.; Ciruelos, Eva; et al, Various; Francis, Prudence; Lluch, Ana; Luo, Weixiu; Pavesi, Lorenzo; Ribi, Karin; School of Public Health: Public HealthAdjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial, Journal of Clinical Oncology, vol.34, 14, 2016,pp 1601-1610
2016Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trialCoates, Alan; Bellet, Meritxell; Bernhard, Jurg; Burstein, Harold J.; Ciruelos, Eva; et al, Various; Francis, Prudence; Lluch, Ana; Luo, Weixiu; Pavesi, Lorenzo; Ribi, Karin; School of Public Health: Public HealthAdjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial, Journal of Clinical Oncology, vol.34, 14, 2016,pp 1601-1610
2003Consensus on medical treatment of metastatic breast cancerStockler, Martin; Beslija, Semir; Bonneterre, Jacques; Burstein, Harold J.; Gnant, Michael; Goodwin, Pamela; Heinemann, Volker; Jassem, J; Köstler, Wolfgang; Krainer, Michael; Menard, Silvie; Miles, David; Petruzelka, Lubos; Possinger, Kurt; Schmid, Peter; Stadtmauer, Edward; Van Belle, Simon; Vogel, Charles; Wilcken, Nicholas; Wiltschke, Christoph; Zielinski, Christoph C.; Zwierzina, Heinz; School of Public Health: NH&MRC Clinical Trials CentreConsensus on medical treatment of metastatic breast cancer, Breast Cancer Research and Treatment, vol.81,(Supplement 1),2003,pp S1-S7
2015Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trialsCoates, Alan; Bernhard, Jurg; Burstein, Harold J.; Colleoni, Marco; et al, Various; Luo, Weixiu; Pinotti, Graziella; Puglisi, Fabio; Ribi, Karin; Ruhstaller, Thomas; Spazzapan, Simon; Tondini, Carlo; School of Public Health: Public HealthPatient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials, The Lancet Oncology, vol.16, 7, 2015,pp 848-858
2009Third consensus on medical treatment of metastatic breast cancerStockler, Martin; Wilcken, Nicholas; Beslija, Semir; Bonneterre, Jacques; Burstein, Harold J.; Cocquyt, Veronique; Gnant, Michael; Heinemann, Volker; Jassem, J; Kostler, Wolfgang J.; Krainer, Michael; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Third consensus on medical treatment of metastatic breast cancer, Annals of Oncology, vol.20, 11, 2009,pp 1771-1785